1. Impurities in new drug substances Q3A (R1), International Conference on Harmonisation, 2002, http://www.ich.org/cache/compo/276-254-1.html
2. Impurities in new drug products Q3B (R2), International Conference on Harmonisation, 2006, http://www.ich.org/cache/compo/276-254-1.html
3. LC–MS and CE–MS strategies in impurity profiling;Niessen;Chimia,1999
4. Why not using capillary electrophoresis in drug analysis?;Holzgrabe;Electrophoresis,2006
5. Capillary electrophoresis for the analysis of small-molecule pharmaceuticals;Altria;Electrophoresis,2006